TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer
Cancer Letters · 2026-03 · 641 · 218271
DOI: 10.1016/j.canlet.2026.218271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-03. Verfasst von Yuan Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China. Hauptthemen laut MEDLINE: Cisplatin, Membrane Proteins, Drug Resistance, Neoplasm, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Cisplatin-based chemotherapy stands as the first-line treatment for metastatic bladder cancer (BCa), yet only 35 % of patients show initial responsiveness, with resistance commonly developing. Therefore, investigating cisplatin-sensitizing targets is warranted for overcoming resistance. In this study, the transmembrane protein 11 (TMEM11) was explored for its role in mediating cisplatin resistance in BCa. Single-cell and bulk RNA sequencing, together with assay for transposase-accessible chromatin using sequencing were utilized. The analyses revealed that TMEM11 was upregulated in cisplatin-resistant cells and associated with mitochondrial metabolic reprogramming and poor prognosis. Spatial transcriptomics and proteomics further confirmed the spatial co-localization of TMEM11 with metabolic pathways enriched in resistant tumors. Functional experiments demonstrated that TMEM11 inhibited BNIP3-mediated mitophagy and apoptosis, thereby stabilizing mitochondrial function to promote cisplatin resistance. Mechanistically, TMEM11 suppressed BNIP3 and impaired mitophagy flux, leading to enhanced survival of cancer cells under cisplatin stress. In vivo, TMEM11 knockdown reduced tumor growth and sensitized tumors to cisplatin treatment. Furthermore, molecular docking and experimental validation identified Curcumin as a high-affinity TMEM11 inhibitor capable of restoring cisplatin sensitivity. This study uncovered the TMEM11-BNIP3 axis as a novel driver of cisplatin resistance in BCa, and proposed pharmacological targeting of TMEM11 as a precise therapeutic strategy to overcome cisplatin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China.
- Department of Urology, Zigong Fourth People's Hospital, Sichuan, 643000, PR China.
- School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong R619, 3 Sassoon Road, Pokfulam, 999077, Hong Kong, China.
- Macao Centre for Research and Development in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, 999078, PR China.
- Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China.
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China; Department of Urology, Baoshan People's Hospital, Baoshan, Yunnan, 678000, PR China. Electronic address: jgzh…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Huang, Y., Chen, C., Su, M., Ye, W., Wei, S., Long, K., Huang, Y., Chen, H., Zhong, Z., Hou, L., Zhang, J., Tan, W., & Li, F. (2026). TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer. Cancer Letters, 641, 218271. https://doi.org/10.1016/j.canlet.2026.218271
Vancouver
Huang Y, Chen C, Su M, Ye W, Wei S, Long K, et al. TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer. Cancer Letters. 2026;641:218271. doi:10.1016/j.canlet.2026.218271
BibTeX
@article{Huang2026,
author = {Huang, Yuan and Chen, Chen and Su, Mingqiang and Ye, Wanteng and Wei, Shu and Long, Kuangye and Huang, Yunjie and Chen, Haiyong and Zhong, Zhangfeng and Hou, Lina and Zhang, Jinge and Tan, Wanlong and Li, Fei},
title = {TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer},
journal = {Cancer Letters},
year = {2026},
volume = {641},
pages = {218271},
doi = {10.1016/j.canlet.2026.218271}
}
EUVIMED